Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genetic Technologies Limited ( - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
GENE
Nasdaq
8071
https://www.gtglabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genetic Technologies Limited (
GTG Global Collaborations and Innovation Update
- Mar 26th, 2024 12:00 pm
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
- Mar 25th, 2024 12:00 pm
One Genetic Technologies Insider Raised Stake By 20% In Previous Year
- Mar 8th, 2024 8:32 pm
GTG to launch U.S. Customer Digital Media Sales Campaign
- Feb 28th, 2024 1:00 pm
Launching our most comprehensive test and expanding into new global markets
- Jan 31st, 2024 1:00 pm
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jan 5th, 2024 1:00 pm
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Dec 29th, 2023 2:00 pm
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
- Dec 14th, 2023 1:00 pm
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
- Dec 12th, 2023 1:00 pm
Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet
- Nov 15th, 2023 8:26 pm
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
- Oct 30th, 2023 12:00 pm
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
- Oct 18th, 2023 12:30 pm
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Oct 6th, 2023 1:00 pm
Genetic Technologies building pathway to profitability
- Sep 27th, 2023 7:40 pm
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
- Sep 27th, 2023 1:00 pm
Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
- Sep 15th, 2023 1:00 pm
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
- Sep 12th, 2023 12:00 pm
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
- Sep 1st, 2023 2:00 pm
Annual Results – Momentum Building on our Commercial Plans
- Aug 30th, 2023 12:45 pm
Genetic Technologies Limited Announces Updated Investor Presentation
- Aug 9th, 2023 12:00 pm
Scroll